Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Glorioso’s company NeuroAge Therapeutics offers tools to track brain health and aging.”
UnverifiableConfidence: LOW

Reasoning

The MIT Technology Review article identifies Glorioso as founder and CEO of NeuroAge Therapeutics and notes that the company offers tools to track brain health and aging. The company's own science page describes a proprietary RNA blood biomarker panel designed as a brain-specific aging clock, confirming the existence of such tracking tools.

On confidence: Multiple independent primary sources directly state that NeuroAge Therapeutics, founded by Christin Glorioso, provides tools for tracking brain health and aging.

Important context

The claim pertains to the existence of tracking tools, not their efficacy or regulatory status.

Evidence

Supporting (3)

Limitations

The evidence confirms the offering of tracking tools but does not provide detailed validation data or third‑party assessments of the tools' performance. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 2, 2026, 5:39 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

A new contest pits competitors against each other in a race to biological youth

MIT Technology Review · Jessica Hamzelou